Hepatitis E Virus Seroprevalence among Adults, Germany

We assessed hepatitis E virus (HEV) antibody seroprevalence in a sample of the adult population in Germany. Overall HEV IgG prevalence was 16.8% (95% CI 15.6%–17.9%) and increased with age, leveling off at >60 years of age. HEV is endemic in Germany, and the lifetime risk for exposure is high.

Detalles Bibliográficos
Autores principales: Faber, Mirko S., Wenzel, Jürgen J., Jilg, Wolfgang, Thamm, Michael, Höhle, Michael, Stark, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471611/
https://www.ncbi.nlm.nih.gov/pubmed/23018055
http://dx.doi.org/10.3201/eid1810.111756
_version_ 1782246451152158720
author Faber, Mirko S.
Wenzel, Jürgen J.
Jilg, Wolfgang
Thamm, Michael
Höhle, Michael
Stark, Klaus
author_facet Faber, Mirko S.
Wenzel, Jürgen J.
Jilg, Wolfgang
Thamm, Michael
Höhle, Michael
Stark, Klaus
author_sort Faber, Mirko S.
collection PubMed
description We assessed hepatitis E virus (HEV) antibody seroprevalence in a sample of the adult population in Germany. Overall HEV IgG prevalence was 16.8% (95% CI 15.6%–17.9%) and increased with age, leveling off at >60 years of age. HEV is endemic in Germany, and the lifetime risk for exposure is high.
format Online
Article
Text
id pubmed-3471611
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-34716112012-10-22 Hepatitis E Virus Seroprevalence among Adults, Germany Faber, Mirko S. Wenzel, Jürgen J. Jilg, Wolfgang Thamm, Michael Höhle, Michael Stark, Klaus Emerg Infect Dis Dispatch We assessed hepatitis E virus (HEV) antibody seroprevalence in a sample of the adult population in Germany. Overall HEV IgG prevalence was 16.8% (95% CI 15.6%–17.9%) and increased with age, leveling off at >60 years of age. HEV is endemic in Germany, and the lifetime risk for exposure is high. Centers for Disease Control and Prevention 2012-10 /pmc/articles/PMC3471611/ /pubmed/23018055 http://dx.doi.org/10.3201/eid1810.111756 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Faber, Mirko S.
Wenzel, Jürgen J.
Jilg, Wolfgang
Thamm, Michael
Höhle, Michael
Stark, Klaus
Hepatitis E Virus Seroprevalence among Adults, Germany
title Hepatitis E Virus Seroprevalence among Adults, Germany
title_full Hepatitis E Virus Seroprevalence among Adults, Germany
title_fullStr Hepatitis E Virus Seroprevalence among Adults, Germany
title_full_unstemmed Hepatitis E Virus Seroprevalence among Adults, Germany
title_short Hepatitis E Virus Seroprevalence among Adults, Germany
title_sort hepatitis e virus seroprevalence among adults, germany
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471611/
https://www.ncbi.nlm.nih.gov/pubmed/23018055
http://dx.doi.org/10.3201/eid1810.111756
work_keys_str_mv AT fabermirkos hepatitisevirusseroprevalenceamongadultsgermany
AT wenzeljurgenj hepatitisevirusseroprevalenceamongadultsgermany
AT jilgwolfgang hepatitisevirusseroprevalenceamongadultsgermany
AT thammmichael hepatitisevirusseroprevalenceamongadultsgermany
AT hohlemichael hepatitisevirusseroprevalenceamongadultsgermany
AT starkklaus hepatitisevirusseroprevalenceamongadultsgermany